Chemogef 250mg Tablet
Marketer
Neon Laboratories Ltd
Salt Composition
Gefitinib (250mg)
Overview Chemogef 250mg Tablet
Afgectin 250mg tablets treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should follow your physician's instructions; continue treatment as directed. Treatment length depends on individual response. Your doctor may recommend regular liver function tests. Common side effects include nausea, diarrhea, dry skin, and decreased appetite. Increased fluid intake may help mitigate side effects. Report any concerning or worsening side effects to your doctor. Immediately report mouth sores, vision changes, or breathing problems. Women should use effective contraception throughout treatment and for one month afterward to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Primary Ingredients of Chemogef 250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Chemogef 250mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Chemogef 250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Chemogef 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Chemogef 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Chemogef 250mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. The 250mg Chemogef tablet can be consumed with or without food, although consistent timing is recommended.
How Chemogef 250mg Tablet works:
Cancrisol 250mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Chemogef 250mg Tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Chemogef 250mg tablets to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Use of the 250mg Chemogef Tablet while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Chemogef 250mg tablets might impair your driving ability due to potential side effects.
KidneyCAUTION
Patients with severe kidney impairment should use Chemogef 250mg tablets cautiously. Dosage modification for Chemogef 250mg tablets may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with liver impairment may generally tolerate Chemogef 250mg Tablets. Preliminary evidence indicates dose modification might be unnecessary; however, physician consultation is recommended.
What if you forget to take Chemogef 250mg Tablet :
Should you forget a Chemogef 250mg Tablet dose, omit it and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Chemogef 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently